| Name | Belaperidone |
|---|---|
| Synonyms |
2,4(1H,3H)-Quinazolinedione, 3-[2-[(1S,5R,6S)-6-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl]-
7566 4DN0TK4892 (+)-3-(2-((1S,5R,6S)-6-(4-Fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl)ethyl)quinazoline-2,4(1H,3H)-dione 3-{2-[(1S,5R,6S)-6-(4-Fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl}-2,4(1H,3H)-quinazolinedione 3-{2-[(1s,5r,6s)-6-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl}quinazoline-2,4(1h,3h)-dione Belaperidone |
| Description | Belaperidone (LU-111995), a 5-HT2A receptor inhibitor, possesses antidopaminergic and antiserotonergic effects[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C22H22FN3O2 |
| Molecular Weight | 379.427 |
| Exact Mass | 379.169617 |
| LogP | 3.39 |
| Index of Refraction | 1.609 |